Nanobiotix S.A. (NBTX) exhibits a robust uptrend across short- and long-term timeframes. The stock has demonstrated consistent price appreciation, outperforming 99% of the broader market on a yearly basis. Over the last 30 days, NBTX has traded within a range of approximately 29 to 36, currently positioned near the upper end. This upward bias is reinforced by rising simple and exponential moving averages, with the price maintaining above critical trendlines. The ADX(14) reading above 49 indicates a strong directional trend, favoring bulls in the near term.
The moving averages for NBTX present a uniformly bullish picture. The 50-day simple MA stands at 33.61, the 100-day at 32.94, and the 200-day at 31.84, all with buy signals as the price trades above these levels. Shorter-term MAs, such as the 20-day at 34.11 (simple) and 34.42 (exponential), further support upward momentum. This alignment suggests sustained buyer control, with no major death crosses evident. The stock's position above the rising 200-day MA underscores the long-term bullish structure.
Momentum indicators align with the prevailing uptrend for NBTX. The RSI(14) hovers around 60, indicating healthy bullish conditions without overextension. MACD(12,26,9) registers at 0.54, with the signal line supporting a buy. Stochastic(9,6) at 70 reflects building strength, while Williams %R at -28 points to potential for further gains. CCI(14) above 90 confirms short-term bullishness. These readings collectively suggest continued positive price action, though traders should monitor for divergence.
Pivot point analysis highlights immediate support at 34.83 (S1), 34.47 (S2), and 34.05 (S3), with the central pivot at 35.25. Resistance levels are noted at 35.61 (R1), 36.03 (R2), and 36.39 (R3). Broader chart levels include support near 30.79 from horizontal zones and resistance in the 32-32.45 area from prior trendlines, though recent action has surpassed these. The 52-week high at 41.89 serves as a major overhead barrier, while lower supports align with key MAs.
Trading volume for NBTX has been moderate, with recent sessions averaging around 76,000 shares. While not exhibiting extreme spikes, volume has accompanied price advances, supporting the uptrend's validity. The stock's beta of 0.58 indicates lower volatility relative to the market, though ATR(14) at 0.82 signals elevated short-term swings. Relative strength metrics show NBTX outperforming peers in the biotech sector.
Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast datasets encompassing technical indicators, price patterns, and historical trends for stocks and ETFs like NBTX. These signals identify potential buy or sell opportunities by recognizing recurring market behaviors and momentum shifts. Traders rely on them to pinpoint entry/exit points, validate trend directions, and enhance decision-making processes. Updated daily, the AI models adapt to evolving conditions, offering a data-driven edge. Explore AI Daily Buy/Sell Signals to integrate advanced analytics into your trading strategy.
Traders are monitoring NBTX for a potential push toward R1 at 35.61 and higher pivot resistance around 36, with the 52-week high at 41.89 as a critical test. A sustained move above the pivot 35.25 could reinforce bullish continuation, while failure to hold S1 34.83 might lead to retests of the 50-day MA near 33.60 or lower supports at 30.79. Key indicators like RSI for overbought conditions, MACD crossovers, and volume confirmation will be pivotal. Any breakdown below major MAs could signal short-term pullback risks.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
A.I.dvisor tells us that NBTX and ALLO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBTX and ALLO's prices will move in lockstep.
| Ticker / NAME | Correlation To NBTX | 1D Price Change % | ||
|---|---|---|---|---|
| NBTX | 100% | -10.38% | ||
| ALLO - NBTX | 30% Poorly correlated | +0.88% | ||
| PBYI - NBTX | 28% Poorly correlated | -0.84% | ||
| CGEN - NBTX | 27% Poorly correlated | -1.39% | ||
| RNAC - NBTX | 27% Poorly correlated | +1.99% | ||
| OABI - NBTX | 27% Poorly correlated | +11.18% | ||
More | ||||